SPECIAL FOCUS SESSION

SF 9a - Hybrid imaging: beyond FDG PET/CT

Lectures

1

SF 9a_3 - Hybrid PET and SPECT for cardiovascular imaging

20:51Albert Flotats, Barcelona / ES

Learning Objectives
1. To learn the clinical need for hybrid imaging in cardiovascular diseases.
2. To consider the role for both PET and SPECT imaging.
3. To learn the range of cardiovascular tracers that are used clinically and their role.

2

SF 9a_1 - Prostate specific membrane antigen (PSMA) hybrid imaging in guiding prostate cancer therapy

23:45Clemens C. Cyran, Munich / DE

Learning Objectives
1. To understand the biology of PSMA.
2. To consider different approaches to imaging PSMA and its use in therapy.
3. To learn about current clinical applications for guiding prostate therapy.

3

SF 9a_2 - Somatostatin receptor imaging and therapy

15:28Luigi Aloj, Cambridge / UK

4

SF 9a_4 - Imaging to guide immuno-oncology

13:59Umar Mahmood, Charlestown, MA / US

Learning Objectives
1. To understand the challenges of imaging response to immunomodulatory therapy.
2. To understand current standard of care imaging for immuno-oncology.
3. To understand some of the novel PET imaging approaches in clinical trials and development.

SF 9a-1	Prostate specific membrane antigen (PSMA) hybrid imaging in guiding prostate cancer therapy Clemens C. Cyran, Munich / DE
	Learning Objectives 1. To understand the biology of PSMA. 2. To consider different approaches to imaging PSMA and its use in therapy. 3. To learn about current clinical applications for guiding prostate therapy.
SF 9a-2	Somatostatin receptor imaging and therapy Luigi Aloj, Cambridge / UK
	Learning Objectives 1. To understand the biology underlying somatostatin-based agents. 2. To consider different approaches to imaging and therapy through the use of the somatostatin receptor. 3. To learn about current clinical applications guiding prostate therapy.
SF 9a-3	Hybrid PET and SPECT for cardiovascular imaging Albert Flotats, Barcelona / ES
	Learning Objectives 1. To learn the clinical need for hybrid imaging in cardiovascular diseases. 2. To consider the role for both PET and SPECT imaging. 3. To learn the range of cardiovascular tracers that are used clinically and their role.
SF 9a-4	Imaging to guide immuno-oncology Umar Mahmood, Charlestown, MA / US
	Learning Objectives 1. To understand the challenges of imaging response to immunomodulatory therapy. 2. To understand current standard of care imaging for immuno-oncology. 3. To understand some of the novel PET imaging approaches in clinical trials and development.